Incidencia y factores asociados al abandono del tratamiento antituberculoso

Incidencia y factores asociados al abandono del tratamiento antituberculoso

Introducción. La tuberculosis es un problema de salud pública. El abandono del tratamiento aumenta la morbimortalidad, continúa el contagio y genera resistencia bacteriana. Es necesario conocer la incidencia y los factores asociados al abandono para desarrollar intervenciones. Objetivo. Determinar l...

Full description

Bibliographic Details
Main Authors:	Flor de María Cáceres, Luis Carlos Orozco
Format:	Article
Language:	English
Published:	Instituto Nacional de Salud 2007-12-01
Series:	Biomédica: revista del Instituto Nacional de Salud
Subjects:	Mycobacterium tuberculosis tuberculosis/therapy drug therapy directly observed therapy treatment refusal incidence
Online Access:	http://www.revistabiomedica.org/index.php/biomedica/article/view/170

Similar Items

Eficacia y eficiencia del tratamiento antituberculoso en jurisdicciones sanitarias de Morelos Efficacy and efficiency of anti-tuberculosis treatment in 2 sanitary jurisdictions of Morelos, Mexico
by: Ma. de Lourdes García-García, et al.
Published: (1998-09-01)

Vigilancia de la resistencia del Mycobacterium tuberculosis a los fármacos antituberculosos, Colombia 2004-2005
by: María Consuelo Garzón, et al.
Published: (2008-09-01)

Multifocal Cutaneous Tuberculosis in an Immunocompetent Patient: A Case Report
by: Mei Y, et al.
Published: (2024-10-01)

Mycobacterial catalases, peroxidases, and superoxide dismutases and their effects on virulence and isoniazid-susceptibility in mycobacteria - a review
by: M. Bartos, et al.
Published: (2004-05-01)

Host-Directed Therapies for Tuberculosis
by: Eui-Kwon Jeong, et al.
Published: (2022-11-01)

Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
by: Yashika Bansal, et al.
Published: (2024-03-01)

Vigilancia de la resistencia a los medicamentos antituberculosos en Cuba, 2010-2011
by: Dihadenys Lemus, et al.
Published: (2014-04-01)

Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice
by: Stefanie Krug, et al.
Published: (2023-04-01)

Metformin as Host-Directed Therapy for TB Treatment: Scoping Review
by: Nikita Naicker, et al.
Published: (2020-04-01)

Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
by: Juan M. Cubillos-Angulo, et al.
Published: (2022-09-01)

Resistencia de Mycobacterium tuberculosis a los fármacos antituberculosos en menores de 15 años en Colombia
by: Claudia Llerena, et al.
Published: (2010-09-01)

NOVEL DRUG DELIVERY SYSTEMS: DESIRED FEAT FOR TUBERCULOSIS
by: Kirtipal Kaur, et al.
Published: (2010-06-01)

Novel drug delivery systems: Desired feat for tuberculosis
by: Kirtipal Kaur, et al.
Published: (2010-01-01)

Impact of Whole-Genome Sequencing of <i>Mycobacterium tuberculosis</i> on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review
by: Druti Hazra, et al.
Published: (2023-12-01)

HIV–TB Coinfection: Current Therapeutic Approaches and Drug Interactions
by: Inesa Navasardyan, et al.
Published: (2024-02-01)

Factores asociados a la no adherencia al tratamiento anti tuberculosis
by: Laura Inés Plata-Casas
Published: (2015-12-01)

Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysisResearch in context
by: Klauss Villalva-Serra, et al.
Published: (2025-01-01)

The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy
by: Deepthi Shankaran, et al.
Published: (2023-01-01)

Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity
by: Ulrich E. Schaible, et al.
Published: (2017-12-01)

Perceptions and experiences of directly observed treatment in tuberculosis: insights from a mixed-methods cross-sectional study
by: Diana Amorim, et al.
Published: (2025-01-01)

New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
by: Lupien, Andréanne, et al.
Published: (2021)

Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
by: Fatemeh Zeynali kelishomi, et al.
Published: (2022-12-01)

Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus
by: Li Zhao, et al.
Published: (2024-01-01)

Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
by: Michel Ntiri, BS, et al.
Published: (2022-11-01)

Implementação do Programa Municipal de Controle da Tuberculose em Marataízes-ES, 2012
by: Érica Marvila Garcia, et al.

Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis
by: Liqun Shao, et al.
Published: (2022-07-01)

Abandono do tratamento de tuberculose utilizando-se as estratégias tratamento auto-administrado ou tratamento supervisionado no Programa Municipal de Carapicuíba, São Paulo, Brasil Noncompliance with tuberculosis treatment involving self administration of treatment or the directly observed therapy, short-course strategy in a tuberculosis control program in the city of Carapicuíba, Brazil
by: Amadeu Antonio Vieira, et al.
Published: (2008-03-01)

Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance
by: Ashirbad Sarangi, et al.
Published: (2024-06-01)

Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis
by: Qingwen Zhang, et al.
Published: (2017-11-01)

Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial
by: Tsegahun Manyazewal, et al.
Published: (2020-05-01)

Host-Directed Therapies and Anti-Virulence Compounds to Address Anti-Microbial Resistant Tuberculosis Infection
by: Raphael Gries, et al.
Published: (2020-04-01)

Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for <i>Mycobacterium tuberculosis</i> Infection—A Review
by: Claudia Sanhueza, et al.
Published: (2023-10-01)

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
by: Vinzeigh N. Leukes, et al.
Published: (2022-07-01)

A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district
by: Dharitri Thakkar, et al.
Published: (2019-01-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis
by: Vera Marie Kroesen, et al.
Published: (2018-04-01)

Nuevos fármacos antituberculosos
by: Jaime Bayona García
Published: (2009-09-01)

Treatment outcomes associated with multidrug-resistant tuberculosis
by: Nitin Gupta, et al.
Published: (2018-01-01)

Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy
by: Gül Kilinç, et al.
Published: (2024-08-01)

Memorias de un sanatorio antituberculoso.
by: Héctor Maldonado, et al.
Published: (2004-06-01)